146 related articles for article (PubMed ID: 3350991)
1. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.
Khoo KC; Givens SV; Parsonnet M; Massarella JW
J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991
[TBL] [Abstract][Full Text] [Related]
2. Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.
Zussman BD; Kelly J; Murdoch RD; Clark DJ; Mbchb ; Schubert C; Collie H
Clin Ther; 2001 Jun; 23(6):921-31. PubMed ID: 11440291
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction of sparfloxacin and digoxin.
Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
[TBL] [Abstract][Full Text] [Related]
4. Single-dose pharmacokinetics and dose proportionality of oral cibenzoline.
Khoo KC; Szuna AJ; Colburn WA; Aogaichi K; Morganroth J; Brazzell RK
J Clin Pharmacol; 1984 Jul; 24(7):283-8. PubMed ID: 6480874
[TBL] [Abstract][Full Text] [Related]
5. Absence of pharmacokinetic interaction between roflumilast and digoxin in healthy adults.
Eckermann G; Lahu G; Nassr N; Bethke TD
J Clin Pharmacol; 2012 Feb; 52(2):251-7. PubMed ID: 21257799
[TBL] [Abstract][Full Text] [Related]
6. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
[TBL] [Abstract][Full Text] [Related]
7. Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia.
Rothbart ST; Saksena S
Am J Cardiol; 1986 Apr; 57(11):941-6. PubMed ID: 3515898
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
Harder S; Thürmann PA
Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral cibenzoline in arrhythmia patients.
Brazzell RK; Colburn WA; Aogaichi K; Szuna AJ; Somberg JC; Carliner N; Heger J; Morganroth J; Winkle RA; Block P
Clin Pharmacokinet; 1985; 10(2):178-86. PubMed ID: 3995859
[TBL] [Abstract][Full Text] [Related]
10. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
Cohen E; Almog S; Staruvin D; Garty M
Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
[TBL] [Abstract][Full Text] [Related]
11. No effect of imidafenacin, a novel antimuscarinic drug, on digoxin pharmacokinetics in healthy subjects.
Nakade S; Ohno T; Nakayama K; Kitagawa J; Hashimoto Y; Ohnishi A; Miyata Y
Drug Metab Pharmacokinet; 2008; 23(2):95-100. PubMed ID: 18445988
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, with coadministration of digoxin.
Stangier J; Stähle H; Rathgen K; Roth W; Reseski K; Körnicke T
J Clin Pharmacol; 2012 Feb; 52(2):243-50. PubMed ID: 21868715
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteers.
Brazzell RK; Khoo KC; Szuna AJ; Sandor D; Aogaichi K; Wills RJ
J Clin Pharmacol; 1985 Sep; 25(6):418-23. PubMed ID: 4056077
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic modeling of cibenzoline plasma concentrations and antiarrhythmic effect.
Holazo AA; Brazzell RK; Colburn WA
J Clin Pharmacol; 1986; 26(5):336-45. PubMed ID: 3700689
[TBL] [Abstract][Full Text] [Related]
15. Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma.
Hashimoto Y; Shibakawa K; Nakade S; Miyata Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):126-32. PubMed ID: 18515196
[TBL] [Abstract][Full Text] [Related]
16. Effect of renal impairment on the pharmacokinetics of cibenzoline.
Massarella JW; Khoo KC; Aogaichi K; Di Persio D; Smith M; Kluger J; Chow MS
Clin Pharmacol Ther; 1988 Mar; 43(3):317-23. PubMed ID: 3345622
[TBL] [Abstract][Full Text] [Related]
17. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
Kothare PA; Soon DK; Linnebjerg H; Park S; Chan C; Yeo A; Lim M; Mace KF; Wise SD
J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study.
Wasty N; Saksena S; Barr MJ
Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875
[TBL] [Abstract][Full Text] [Related]
19. The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects.
Zhou H; Horowitz A; Ledford PC; Hubert M; Appel-Dingemanse S; Osborne S; McLeod JF
J Clin Pharmacol; 2001 Oct; 41(10):1131-9. PubMed ID: 11583482
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum).
Johne A; Brockmöller J; Bauer S; Maurer A; Langheinrich M; Roots I
Clin Pharmacol Ther; 1999 Oct; 66(4):338-45. PubMed ID: 10546917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
